Has Lamont Hornbeck, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,767 in general payments to Lamont Hornbeck, MD across 52 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lamont Hornbeck, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lamont Hornbeck, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lamont Hornbeck, MD

Procedural Dermatology · Roseville, CANPI 1871522664

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.8% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 28.3% of the total. Reporting peaked in 2019 at $910 and has fallen 98.2% since, to $16 in 2025. That places this record below the midpoint for procedural dermatology clinicians in CA, where the typical reported total is $2,566.

$1,767in general payments, 2019–2025

Across 52 payments — averaging $33.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$500
Johnson & Johnson$194
Amgen$169
Regeneron Healthcare Solutions, Inc.$162
Janssen Scientific Affairs, LLC$125
DUSA Pharmaceuticals, Inc.$124
plus $493 from 12 others

What the payments were for

Food & beverage$1,60491%
Education$1639%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	11	$500
Johnson & Johnson	5	$194
Amgen	4	$169
Regeneron Healthcare Solutions, Inc.	4	$162
Janssen Scientific Affairs, LLC	1	$125
DUSA Pharmaceuticals, Inc.	1	$124
Genentech USA, Inc.	4	$95
Lilly USA, LLC	4	$91
LEO Pharma Inc.	3	$64
Pfizer	3	$48
Galderma Laboratories, L.p.	3	$41
Sanofi	2	$39
Sun Pharmaceutical Industries Inc.	1	$23
Biofrontera Inc.	2	$22
Merz North America, Inc.	1	$21
Merck	1	$19
Incyte Corporation	1	$15
Pierre Fabre Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,767 in reported general payments places this provider in the 45th percentile of 108 procedural dermatology providers in California.

See all procedural dermatology providers in California →

Medicare billing

Part B allowed, 2024

$249,005

Medicare patients

263

Services billed

2,768

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Enbrel SureclickEtanercept	13	$189,649
Humira(Cf) PenAdalimumab	13	$79,591
Fluorouracil	20	$1,510
Clobetasol Propionate	26	$1,407
Fluocinonide	30	$1,093
Doxycycline Hyclate	27	$926
Metronidazole	17	$844
ValacyclovirValacyclovir Hcl	13	$515
Hydrocortisone	38	$389
Triamcinolone Acetonide	19	$329
Imiquimod	11	$281
Prednisone	20	$278
Alprazolam	13	$116

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Roseville

Sam Khalifianla Mesa$3.5M
Sabrina FabiSan Diego$3.1M
Natasha MesinkovskaMission Viejo$499K
Jeanette BlackLos Angeles$492K
Mitchel GoldmanSan Diego$425K
Rebecca FitzgeraldLos Angeles$230K
Suzanne KilmerSacramento$220K
Zakia RahmanStanford$181K
Hrak JalianSanta Monica$160K
Amelia HausauerCampbell$117K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →